AN BFL-1 BINDENDE PEPTIDE

Patent europeic · EP3341008 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3341008
Numer da la dumonda
EP16842712
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-08-2016
Publitgà
04-07-2018
Concedì
15-04-2026
La protecziun finescha il pli tard
25-08-2036
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61K 38/12 (2006.01)
C07K 14/00 (2006.01)
Prioritad
US 201562211680 P 28.08.2015
Dumonda PCT
PCT/US2016/049095 26.08.2016
Publicaziun PCT
WO2017/040329 09.03.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 19-05-2026

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 19.05.2026

  3. 15-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.04.2026

Partidas

Possessur

Dana-Farber Cancer Institute, Inc.

450 Brookline Avenue, Boston, MA 02115-5450, US

Represchentant

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventur

WALENSKY, Loren D.

Newton Centre, Massachusetts 02459, US

BIRD, Gregory H.

Pelham, New Hampshire 03076, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.